Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Rhabdoid Tumor 1Medulloblastoma 1Glioma 1Familial ependymoma 1Diffuse Intrinsic Pontine Glioma 1Cystadenocarcinoma, Serous 1Breast Neoplasms 1

Interventions

Vincristine 3Thiotepa 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Etoposide 2Cyclophosphamide 2Cisplatin 2Carboplatin 2ribociclib 1merphos 1lonafarnib 1etoposide phosphate 1Topotecan 1Temozolomide 1Stem Cell Transplantation 1Radiotherapy, Conformal 1Radiotherapy 1Psychiatric Rehabilitation 1Platinum 1Peripheral Blood Stem Cell Transplantation 1Oxaliplatin 1Neoadjuvant Therapy 1Methotrexate 1Leucovorin 1Irinotecan 1Immunohistochemistry 1Gene Expression Profiling 1Everolimus 13-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Rhabdoid Tumor × ribociclib × Clear all
NCT03387020 2021-08-27

Ribociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain Tumors

Pediatric Brain Tumor Consortium

Phase 1 Completed
22 enrolled 16 charts
CNS

Familial ependymoma, Diffuse Intrinsic Pontine Glioma, Glioma, Medulloblastoma, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡